Johnson & Johnson in Talks to Buy Protagonist Therapeutics: WSJ

Johnson & Johnson in Talks to Buy Protagonist Therapeutics: WSJ

Johnson & Johnson is in talks to purchase Protagonist Therapeutics Inc., the Wall Street Journal reported, citing people familiar with the matter.

Johnson & Johnson in Talks to Buy Protagonist Therapeutics

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.

Protagonist Therapeutics (PTGX) Skyrockets on J&J Buyout Buzz Amid Clinical Breakthroughs

Recent News and Corporate Developments J&J Buyout Buzz: The biggest news propelling Protagonist’s stock is the report that Johnson & Johnson is in talks to acquire Protagonist reuters.com. On October 10, 2025, The Wall Street Journal broke the story (later confirmed by Reuters) that J&J is negotiating a purchase of Protagonist Therapeutics reuters.com. This potential acquisition would build on the companies’ ongoing partnership: J&J’s Janssen un…

Johnson amp; Johnson In Talks To Acquire Protagonist Therapeutics: Report

Johnson & Johnson (NYSE:JNJ) is reportedly in discussions to …